Bristol-Myers Squibb (BMY) Declares $0.37 Quarterly Dividend; 2.4% Yield

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. SBUX
9. AXP
10. ZETA

Go back to Bristol-Myers Squibb (BMY) Declares $0.37 Quarterly Dividend; 2.4% Yield

Bristol-Myers Squibb (BMY) Announces FDA Acceptance of Supplemental Yervoy BLA as Adjuvant Melanoma Treatment

March 2, 2015 9:26 AM EST

Bristol-Myers Squibb (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review the supplemental Biologics License Application (sBLA) for Yervoy for the adjuvant treatment of patients with stage 3 melanoma who are at high risk of recurrence following complete surgical... More